Dr. rer. nat. Thomas Kammertöns
Charité - Universitätsmedizin Berlin
Charité Campus Buch
Experimental and Clinical Research Center
Lindenberger Weg 80
13125 Berlin
Email: tkamm(at)mdc-berlin.de
University Education
- 1989-1996 Biology und North American Studies, FU Berlin
- 1994-1995 Fulbright scholarship, Vanderbilt University, USA
- 1996-2001 Ph.D., MDC
Professional Experience (selection)
- 2001-2004 Staff scientist at the MDC
- Since 2004 Staff scientist and teaching coordinator at the Institute of Immunology, Charité
Research Fields
- i) Tumor immunology
- ii) Immunology
- iii) Gene therapy
Most important Awards, Grants or Scientific Achievements
- PI Research Training Group SFB/TRR 36, PI Project B1 SFB/TRR 36
Group Members
- Christian Friese - Technician (molecular biology, cellular immunology)
- Georg Hilfenhaus – Clinician Scientist (Departmentof hematology, oncology and tumor immunology, CCM)
Selected References
- Kemna, J., Gout, E., Daniau, L., Lao, J., Weißert, K., Ammann, S., Kühn, R., Richter, M., Molenda, C., Sporbert, A., Zocholl, D., Klopfleisch, R., Lortat-Jacob, H., Aichele, P., Kammertoens, T., Blankenstein, T. IFNγ binding to extracellular matrix prevents fatal systemic toxicity. Nat Immunol (2023). doi.org/10.1038/s41590-023-01420-5
- Garnier, L., Pick, R., Montorfani, J., Sun, M., Brighouse, D., Liaudet, N., Kammertoens, T., Blankenstein, T., Page, N., Bernier-Latamani, J., Tran, N.L., Petrova, T.V., Merkler, D., Scheiermann, C., Hugues, S. IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci Adv. 2022 Jun 10;8(23):eabl5162. doi: 10.1126/sciadv.abl5162. PMID: 35675399.
- Jeuthe, S., Kemna, J., Kemna, C.P., Zocholl, D., Klopfleisch, R., Palme, R., Kirschbaum, C., Thoene-Reineke, C., Kammertoens, T. Stress hormones or general well-being are not altered in immune-deficient mice lacking either T- and B- lymphocytes or Interferon gamma signaling if kept under specific pathogen free housing conditions. PLoS One. 2020 doi: 10.1371/journal.pone.0239231. PMID: 32997686.
- Schreiber, K., Karrison, T.G., Wolf, S.P., Kiyotani, K., Steiner, M., Littmann, E.R., Pamer, E.G., Kammertoens, T., Schreiber, H., Leisegang, M. Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors. Cancer Immunol Res. 2020. 8(2):192-202. doi: 10.1158/2326-6066.CIR-19-0567. PMID: 31831634.